Stay updated on DoceRamPem in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DoceRamPem in NSCLC Clinical Trial page.

Latest updates to the DoceRamPem in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-26.SummaryDifference1.0%
- Check66 days agoChange DetectedThe page has updated the date for the Phase 2 DoceRamPem trial for patients with metastatic or recurrent NSCLC from February 13, 2024, to February 26, 2025.SummaryDifference1.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to DoceRamPem in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DoceRamPem in NSCLC Clinical Trial page.